Uncategorized

A crowded pool

According to a story on the MassDevice web site Nest is jumping into the healthcare pool which by default means that diabetes care will be part of the effort. Per the story; “Connected home device maker Nest, which was bought by Google (NSDQ:GOOG) in 2014 for $3.2 billion, acquired smartphone-based health monitoring system developer Senosis Health last year in a hush-hush deal that may mark the business’ first steps towards an...

Duh

“A 2015 study of Humana associates enrolled in Go365, the company’s rewards program, found that members who were actively engaged over three years had lower average claim costs and absenteeism rates. Since the companies partnered in 2013, members have used their health rewards points to redeem more than 170,000 Fitbit devices, the companies said.” This quote comes from a story posted on the FireceBiotech web site and is just further evidence...

As the world turns

To say there are lots of ironies in our wacky world is like saying there are lots of trees in the forest. We thought of this rather strange analogue while updating our calendrer deciding which earnings calls we should listen to and which we can leave for a transcript read. With third quarter results coming there are several questions for which we and investors would like some answers. Irony #1- The...

Watch out Alexa

One of the best Miller Lite commercials ever was called the cat fight, well it seems another cat fight is brewing in our wacky world. Say hello to Sophia from Novo Nordisk. Yep Sophia is Novo’s answer to snarky Alexa and her current rival Siri. And before we go any further we really think Google should come up with a female name for their digital assistant. One more thing why...

Let’s call it what it is

Back in the day Momma Kliff, someone as we all know isn’t one to mince words, used to tell us don’t be afraid to call out bullshit when you see it. Others may try and sugarcoat things or put lipstick on a pig but when you strip away all the crap bullshit is just that bullshit. We thought of Mom today when heard that UnitedHealthcare has deemed the Tandem t:slim insulin...

Not Shocking

Everyone should have seen this coming, so it should surprise no one that Tandem shares fell nearly 16% yesterday or that Insulet and Dexcom feel. As we have noting these three stocks have been hotter than, and damn it’s getting difficult to find new adjectives to describe how hot they have been. The question becomes is the party over or are investors just taking a breather? Of the three stocks we...

Imagine the possibilities

As everyone knows CGM is rapidly replacing BGM as the standard for glucose measurement. However, this does not mean that BGM isn’t being used anymore, far from it. JNJ was able to unload their LifeScan unit for a little over $2 billion and while not as profitable as it was once was there is still plenty of money to be made selling test strips. The key is as it always...

Zapping diabetes

Before we get into our musings for today our prayers go out to everyone impacted by Hurricane Florence. To our many friends in the area be safe. Now onto the show…… You just knew this coming per a story on the Medical Design and Outsourcing web site; “GE and DARPA are collaborating on a $2.9 million study of neuromodulation as a treatment for Type 2 diabetes. GE scientists have developed a novel, potentially breakthrough...

Way cool way useless

We truly believe when it comes to diabetes research the motto isn’t is this needed to be done rather hey let’s do this because it can be done. This is particularly true with all the new way cool whiz bang technology that is flooding diabetes. Here is a perfect example of what we are talking about per a post on the VentureBeat web site; “Researchers have developed an artificially intelligent (AI)...

A Swap and more

This summer there was a series of trades in the NFL at the most important position, quarterback. What made these trades unusual was it wasn’t a bunch of second stringers changing uniforms but starters. Well it looks like the wacky world is following the NFL as per a story in Reuters; “Bayer, which is revamping its drug development activities, is losing the head of its pharmaceuticals division Dieter Weinand, who will...